Association for Value-Based Cancer Care, Inc.
For Immediate Release:
May 8, 2014. The Association for Value-Based Cancer Care (AVBCC) has recognized 3 poster award winners at its Fourth Annual AVBCC Conference. Healthcare professionals, oncology practice managers, and managed care executives were invited to submit an abstract for AVBCC’s Fourth Annual Conference, giving them an opportunity to share research, programs, and insights with colleagues.
The following individuals were awarded the opportunity to present their research findings to the audience for their outstanding submissions:
- Jacqueline Hall, Marco daCosta DiBonaventura, Ronda Copher, Claudio Faria, and Rose Lorenzo for their poster titled, “Out-of-Pocket Costs Among Women with Metastatic Breast Cancer.” Category: Policy, Advocacy, and Economy
Using a survey methodology, Hall and colleagues demonstrated a significant association between U.S. region and monthly Out-of-Pocket (OOP) breast cancer treatment costs; women in the Midwest reported the highest OOP costs compared with women in other regions. OOP costs also trended upward with increasing socioeconomic variables (e.g., education, income, insurance coverage), suggesting a greater ability and willingness to pay OOP costs among these subgroups.
- Nicolas Lewine, Doria Cole, Brandon Wade, and Gary Gustavsen for their poster titled “Budget Impact Analysis of a Novel Gene Expression Assay for the Diagnosis of Malignant Melanoma.” Category: Implications of Personalized Medicine on Payers in Realizing Cost Efficiency
Speaking for the winners in this category, Gary Gustavsen stated, “We are very excited about this work. Costs surrounding cancer care are exploding and technologies like myPath Melanoma are going to be critical in bringing both clinical and economic efficiencies to the system.”
- Shaji K. Kumar, Ann E. Engebretson, Francis K. Buadi, Martha Q. Lacy, Angela Dispenzieri, Mei Sheng Duh, Marie-Hélène Lafeuille, Patrick Lefebvre, Wendy Cheng, Katherine Dea, Mark Yap, Shanmugapriya Saravanan, Debra Rembert, Debra Patt, Liviu Niculescu, Esprit Ma, Maureen Quick, and S. Vincent Rajkumar for their poster titled “Comparable Outcomes and Lower Total Healthcare Cost with Bortezomib-Cyclophosphamide-Dexamethasone Compared to Bortezomib-Lenalidomide-Dexamethasone for Initial Treatment of Newly Diagnosed Multiple Myeloma (MM).” Category: Oncology Practice Management, Navigation, and Advocacy: Patient and Survivor Care
Esprit Ma described the study findings: “... retrospective analysis of data in routine oncology clinical settings evaluated the incremental benefits and harms of alternative treatment options in newly-diagnosed MM. Comparable outcomes in terms of response, progression-free survival, overall survival, and well-tolerated safety profiles were observed between bortezomib-cyclophosphamide-dexamethasone (VCD) and bortezomib-lenalidomide-dexamethasone (VRD) as initial therapies in MM.”
Award winners presented their data to an audience of more than 250 people during the Fourth Annual AVBCC Conference, May 6-9, 2014, at The Loews Hollywood Hotel in Los Angeles, California.
The AVBCC Conference provides an opportunity for healthcare professionals, oncology practice managers, and managed care executives to learn from leaders in cancer care, healthcare policy, and managed care. Information shared at this meeting helps attendees improve and sustain their companies and institutions, while improving patient access and quality of cancer care.
Highlights and interviews from the Fourth Annual AVBCC Conference will be featured in an upcoming issue of Value-Based Cancer Care®, the official publication of AVBCC. This journal provides a forum for payers, providers, and the entire oncology team to consider cost-value issues particular to cancer treatments.
About the Association for Value-Based Cancer Care™ (AVBCC) www.avbcconline.org
The mission of AVBCC is to provide a forum for payers, providers, and the entire oncology team to consider and evaluate the cost-value issues particular to cancer treatments and its impact on patient care and outcomes. This unique focus is achieved through discussions and collaborations with those involved in evaluating therapies, treating patients, and paying for care.
AVBCC is the fastest growing national specialty organization dedicated to improving the care of cancer patients and their quality of life, by discussing, considering, and evaluating the value equation as it relates to new and existing cancer therapies. This organization, which currently consists of more than 500 members, was established to provide a network for payers and oncology healthcare professionals to interact and network in order to promote optimal care for patients and their families.
About Value-Based Cancer Care® (VBCC) www.valuebasedcancer.com
VBCC is the official publication of the Association for Value-Based Cancer Care. The journal provides a forum for payers, providers, and the entire oncology team to consider the cost-value issues particular to cancer treatments. This unique focus is achieved through news coverage from major hematology/oncology meetings and the cancer literature, supplemented with commentaries and perspectives from those involved in evaluating therapies, treating patients, and paying for care.